Evidence map›Paper›PMID 42137457›Full record

ArticleOncology letters2026

Diagnostic and therapeutic challenges of locally advanced colon cancer complicated with acute lymphoblastic leukemia: A case report.

Yuping Zeng, Song Mu, Guosheng Li, Zhengzi Liang, Qinghua Ji, Yunhuan Zhen, Wenling Wang, Weiwei Chen

Abstract readCase Reports
In one paragraph

Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuping ZengColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Song MuColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Guosheng LiColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Zhengzi LiangColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Qinghua JiColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Yunhuan ZhenColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Wenling WangColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.
Weiwei ChenColorectal Tumor Center, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou 550004, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colorectal cancer (CRC) is the second most common malignant tumor in China, characterized by a steadily increasing annual incidence. Acute lymphoblastic leukemia (ALL) is a malignant clonal disorder originating from lymphoid progenitor cells that predominantly affects children and adolescents. Its incidence is relatively lower in adults than in children, however they typically experience poorer prognoses. Although CRC and ALL each have distinct pathological and epidemiological profiles, their coexistence as synchronous or metachronous double primary malignancies in the same patient is rare and their treatment strategies differ. The current study presents a case of locally advanced colon cancer concurrent with ALL, in which the patient underwent radical colon cancer surgery after achieving complete remission of ALL through induction chemotherapy.

Indexed as

acute lymphoblastic leukemiacolorectal cancerdouble primary cancermultidisciplinary team

Identifiers

PMID42137457
PMCPMC13169109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.